{
    "clinical_study": {
        "@rank": "154614", 
        "arm_group": {
            "arm_group_label": "NKTT120", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine the safety, pharmacokinetics, and pharmacodynamics\n      of NKTT120 in adult patients with stable sickle cell disease."
        }, 
        "brief_title": "Safety, Pharmacokinetic, and Pharmacodynamic Study of NKTT120 in Adult Patients With Stable Sickle Cell Disease (SCD)", 
        "condition": "Sickle Cell Disease", 
        "condition_browse": {
            "mesh_term": "Anemia, Sickle Cell"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Age 18 to 50 years\n\n          -  Subject has a confirmed diagnosis of HbSS or HbS\u03b20thal\n\n          -  Subject has stable SCD defined as not having acute VOC, ACS, or other major SCD\n             associated event during the month prior to enrollment\n\n        Exclusion Criteria:\n\n          -  Subject had an SCD-related VOC or ACS that required hospitalization or treatment in\n             acute care outpatient setting in the month prior to enrollment\n\n          -  Subject requires a program of prescheduled regularly administered packed red blood\n             cell (pRBC) transfusions or Subject received a pRBC transfusion in the month prior to\n             enrollment\n\n          -  Subject has evidence of latent or active tuberculosis\n\n          -  Subject has a major concurrent illness or medical condition\n\n          -  Subject is pregnant or nursing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "21", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 1, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01783691", 
            "org_study_id": "120-SCD1"
        }, 
        "intervention": {
            "arm_group_label": "NKTT120", 
            "intervention_name": "NKTT120", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": "Sickle cell disease", 
        "lastchanged_date": "April 30, 2014", 
        "location": [
            {
                "contact": {
                    "email": "mstewart@mail.cho.org", 
                    "last_name": "Melanee Stewart", 
                    "phone": "510-428-3885", 
                    "phone_ext": "7949"
                }, 
                "contact_backup": {
                    "email": "llavrisha@mail.cho.org", 
                    "last_name": "Lisa Lavrisha, PNP", 
                    "phone": "510-428-3885", 
                    "phone_ext": "4376"
                }, 
                "facility": {
                    "address": {
                        "city": "Oakland", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "94609"
                    }, 
                    "name": "Children's Hospital & Research Center at Oakland"
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Baltimore", 
                        "country": "United States", 
                        "state": "Maryland", 
                        "zip": "21205"
                    }, 
                    "name": "Johns Hopkins School of Medicine"
                }, 
                "status": "Active, not recruiting"
            }, 
            {
                "contact": {
                    "email": "jwitkin@partners.org", 
                    "last_name": "Joanna Witkin, MS", 
                    "phone": "617-278-0377"
                }, 
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts", 
                        "zip": "02115"
                    }, 
                    "name": "Brigham and Women's Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "garrett_l@kids.wustl.edu", 
                    "last_name": "Lisa Garrett, RN", 
                    "phone": "314-286-1208"
                }, 
                "facility": {
                    "address": {
                        "city": "St. Louis", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "63110"
                    }, 
                    "name": "Washington University School of Medicine"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "susan_jones@med.unc.edu", 
                    "last_name": "Susan K Jones, RN", 
                    "phone": "919-966-6876"
                }, 
                "facility": {
                    "address": {
                        "city": "Chapel Hill", 
                        "country": "United States", 
                        "state": "North Carolina", 
                        "zip": "27514"
                    }, 
                    "name": "UNC Sickle Cell Program"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "debora.nischik@bcw.edu", 
                    "last_name": "Debora Nischik, RN CCRC", 
                    "phone": "414-937-6457"
                }, 
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin", 
                        "zip": "53226"
                    }, 
                    "name": "Blood Center of Wisconsin"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "A Single Ascending Dose Phase 1 Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Biologic Activity of Intravenous NKTT120 in Adults With Stable Sickle Cell Disease", 
        "other_outcome": [
            {
                "measure": "Pain scores as assessed by daily electronic diary", 
                "safety_issue": "No", 
                "time_frame": "Daily for 120 days"
            }, 
            {
                "measure": "Quality of Life as assessed by two separate Quality of Life instruments", 
                "safety_issue": "No", 
                "time_frame": "0, 30, 60, 90, 120 days"
            }, 
            {
                "measure": "Lung function as measured by pulmonary function tests", 
                "safety_issue": "No", 
                "time_frame": "0; 30 minutes; 30, 60, 90, 120 days"
            }
        ], 
        "overall_contact": {
            "email": "ceaton@nktrx.com", 
            "last_name": "Cheryl Eaton", 
            "phone": "7816840290"
        }, 
        "overall_official": {
            "affiliation": "NKT Therapeutics", 
            "last_name": "Rosemary Mazanet, MD", 
            "role": "Study Director"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Safety as assessed by (1) adverse events (2) laboratory values (3) vital signs and (4) physical exam.", 
            "safety_issue": "Yes", 
            "time_frame": "180 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01783691"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Pharmacokinetics assessed by plasma drug concentration levels", 
                "safety_issue": "No", 
                "time_frame": "0; 15, 30, 60 minutes; 3,6, hours; 1,2,3,7,14,30,60,90 days"
            }, 
            {
                "measure": "Pharmacodynamics as measured by assessments of peripheral blood lymphocyte subsets", 
                "safety_issue": "No", 
                "time_frame": "0, 0.25, 1, 2, 7, 14, 30, 60, 90, 120 days"
            }
        ], 
        "source": "NKT Therapeutics", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "NKT Therapeutics", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}